Cargando…
Tranexamic acid in pediatric trauma: why not?
Trauma is a leading cause of death in pediatrics. Currently, no medical treatment exists to reduce mortality in the setting of pediatric trauma; however, this evidence does exist in adults. Bleeding and coagulopathy after trauma increases mortality in both adults and children. Clinical research has...
Autores principales: | Beno, Suzanne, Ackery, Alun D, Callum, Jeannie, Rizoli, Sandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095612/ https://www.ncbi.nlm.nih.gov/pubmed/25043066 http://dx.doi.org/10.1186/cc13965 |
Ejemplares similares
-
The Use of Tranexamic Acid in Rhytidectomy Patients
por: Butz, Daniel R., et al.
Publicado: (2016) -
The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective
por: Wood, Brendan, et al.
Publicado: (2017) -
Why It Is Important to Develop an Effective and Safe Pediatric COVID-19 Vaccine
por: Principi, Nicola, et al.
Publicado: (2021) -
Recombinant factor VIIA is associated with an improved 24‐hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients
por: Nascimento, Bartolomeu, et al.
Publicado: (2011) -
A systematic review on the rotational thrombelastometry (ROTEM®) values for the diagnosis of coagulopathy, prediction and guidance of blood transfusion and prediction of mortality in trauma patients
por: Veigas, Precilla V., et al.
Publicado: (2016)